Mochida Pharmaceutical Co.,Ltd. Logo

Mochida Pharmaceutical Co.,Ltd.

Develops and sells pharmaceuticals, healthcare products, and medical devices.

4534 | T

Overview

Corporate Details

ISIN(s):
JP3922800002
LEI:
Country:
Japan
Address:
新宿区四谷一丁目7番地

Description

Mochida Pharmaceutical Co., Ltd. is a research-driven company focused on the development, manufacturing, and sale of pharmaceuticals, healthcare products, and medical devices. The company's core pharmaceutical business concentrates on therapeutic areas such as cardiovascular diseases, with a key focus on circulatory agents. It is also active in other fields, including oncology, through partnerships for generic products. In its healthcare segment, Mochida develops and markets functional, low-irritating products based on dermatological science. Additionally, the company distributes medical instruments and equipment for diagnostic and surgical applications, contributing to a broad spectrum of medical care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-02-14 01:24
四半期報告書-第84期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese 164.6 KB
2021-11-12 02:20
四半期報告書-第84期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese 199.6 KB
2021-08-06 06:16
四半期報告書-第84期第1四半期(令和3年4月1日-令和3年6月30日)
Japanese 159.4 KB
2021-06-29 08:40
確認書
Japanese 9.1 KB
2021-06-29 08:39
内部統制報告書-第83期(令和2年4月1日-令和3年3月31日)
Japanese 23.6 KB
2021-06-29 08:38
有価証券報告書-第83期(令和2年4月1日-令和3年3月31日)
Japanese 1.0 MB
2021-02-12 01:13
四半期報告書-第83期第3四半期(令和2年10月1日-令和2年12月31日)
Japanese 157.6 KB
2020-11-12 01:02
四半期報告書-第83期第2四半期(令和2年7月1日-令和2年9月30日)
Japanese 193.9 KB
2020-08-07 02:13
四半期報告書-第83期第1四半期(令和2年4月1日-令和2年6月30日)
Japanese 149.9 KB
2020-06-26 06:46
有価証券報告書-第82期(平成31年4月1日-令和2年3月31日)
Japanese 1014.1 KB
2020-02-13 02:01
四半期報告書-第82期第3四半期(令和1年10月1日-令和1年12月31日)
Japanese 230.0 KB
2019-11-12 01:34
四半期報告書-第82期第2四半期(2019/07/01-2019/09/30)
Japanese 271.3 KB
2019-08-09 02:34
四半期報告書-第82期第1四半期(2019/04/01-2019/06/30)
Japanese 226.7 KB
2019-06-27 07:22
有価証券報告書-第81期(平成30年4月1日-平成31年3月31日)
Japanese 998.4 KB
2019-02-13 01:34
四半期報告書-第81期第3四半期(2018/10/01-2018/12/31)
Japanese 222.7 KB

Automate Your Workflow. Get a real-time feed of all Mochida Pharmaceutical Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mochida Pharmaceutical Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mochida Pharmaceutical Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.